SCHEMBL20164165

SCHEMBL20164165

C=CCC(NC(=O)O)C(=O)NC(C)c1ccccc1[N+](=O)[O-]

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
CYP1A2 P05177 3/20 0.41
TSHR P16473 1/20 0.41
POLB P06746 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C19 P33261 1/20 0.38
LMNA P02545 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GLA P06280 1/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
GAA P10253 1/20 0.36
CTSL P07711 1/20 0.36
CTSB P07858 1/20 0.36
CYP2D6 P10635 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20164163 1.00 ALDH1A1 (0.42) ALDH1A1CYP1A2TSHRPOLBCYP3A4
SCHEMBL21442832 0.85 ALDH1A1 (0.40) ALDH1A1MAPTCTSLCTSB
SCHEMBL20181221 0.85 ALDH1A1 (0.40) ALDH1A1MAPTCTSLCTSB
SCHEMBL1694362 0.81 ALDH1A1 (0.56) ALDH1A1CYP1A2TSHRPOLBCYP3A4
SCHEMBL20592102 0.81 ALDH1A1 (0.56) ALDH1A1CYP1A2TSHRPOLBCYP3A4
SCHEMBL20164184 0.81 KDM4E (0.37) ALDH1A1POLBCYP2C19MEN1KMT2A
SCHEMBL20164187 0.81 KDM4E (0.37) ALDH1A1POLBCYP2C19MEN1KMT2A
SCHEMBL28615073 0.79 ALDH1A1 (0.43) ALDH1A1CYP1A2TSHRPOLBCYP3A4
SCHEMBL28615074 0.79 ALDH1A1 (0.43) ALDH1A1CYP1A2TSHRPOLBCYP3A4
SCHEMBL20164169 0.78 MEN1 (0.47) ALDH1A1POLBCYP3A4CYP2C19LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3310777-B1 DIAMIDE MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2019-10-09 EP disclosed
US-10160750-B2 Diamide macrocycles as factor XIa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2018-12-25 US disclosed
US-20180141932-A1 DIAMIDE MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141932-A1 DIAMIDE MACROCYCLES AS FACTOR XIA INHIBITORS TFPI, TFPI2, F11 ALDH1A1 4091/4885CYP1A2 1319/4885TSHR 2418/4885
US-10160750-B2 Diamide macrocycles as factor XIa inhibitors TFPI, TFPI2, F11 ALDH1A1 4091/4885CYP1A2 1319/4885TSHR 2418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.